Advarra presents free clinical research resources during COVID-19 crisis
The research consulting and solutions provider will offer complimentary transfer of IRB oversight, access to eRegulatory software and more.
Archives for April 2, 2020
FDA requests recall of ranitidine drug products
The agency is asking manufacturers to withdraw all products containing ranitidine due to contamination concerns around a possible carcinogen.